P3 Therapeutics is a preclinical biotech startup from Zagreb, Croatia. We are developing small chemical molecules to treat chronic inflammation and “leaky gut” in chronic immune-mediated diseases (IMIDs), like spondyloarthritis or IBD. Our network pharmacology solutions offer fundamental shift innovation in spondyloarthritis (SpA) causal treatment.
Back
Gallery
